Two inspections by the US Food and Drug Administration, an internal company investigation, and an inspection by a third party found instances of misconduct and other violations at a Cetero Research facility in Houston, reports Reuters. "The pattern of misconduct was serious enough to raise concerns about the integrity of the data Cetero generated during the five-year time frame," FDA said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.